BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2020 12:21:39 PM | Browse: 921 | Download: 2240
 |
Received |
|
2020-03-06 12:51 |
|
Peer-Review Started |
|
2020-03-06 12:52 |
|
First Decision by Editorial Office Director |
|
2020-04-12 17:06 |
|
Return for Revision |
|
2020-04-15 01:58 |
|
Revised |
|
2020-06-03 12:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-07-01 10:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-07-04 03:58 |
|
Articles in Press |
|
2020-07-04 03:58 |
|
Edit the Manuscript by Language Editor |
|
2020-07-07 23:57 |
|
Typeset the Manuscript |
|
2020-07-21 17:16 |
|
Publish the Manuscript Online |
|
2020-07-24 12:21 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Restenosis after recanalization for Budd-Chiari syndrome: Management and long-term results of 60 patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei Zhang, Yu-Long Tian, Qiao-Zheng Wang, Xiao-Wei Chen, Qi-Yang Li, Jin-Hang Han, Xu-Dong Chen and Ke Xu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ke Xu, MD, PhD, Professor, Department of Interventional Radiology, The First Affiliated Hospital of China Medical University, 155 Nanjing Bei Street, Shenyang 110001, Liaoning Province, China. kexu@vip.sina.com |
| Key Words |
Budd-Chiari syndrome; Restenosis; Long-term follow-up; Treatment strategy; ; |
| Core Tip |
This is the first study to explore the treatment strategy for restenosis in Chinese patients with Budd-Chiari syndrome after interventional therapy and evaluate the outcomes with more than 20-year follow-up. The 1-, 5-, 10-, 20- and 25-year cumulative survival rates of the 38 patients who received further treatment after restenosis were 100%, 78.3%, 78.3%, 70.5% and 70.5%, respectively; however, for the 22 patients who refused treatment, the survival rates were 72.7%, 45.9%, 30.6%, 10.2% and unavailable, respectively (P < 0.001). Regular follow-up and active treatment can result in satisfactory prognosis in Budd-Chiari syndrome patients with restenosis. |
| Publish Date |
2020-07-24 12:21 |
| Citation |
Zhang W, Tian YL, Wang QZ, Chen XW, Li QY, Han JH, Chen XD, Xu K. Restenosis after recanalization for Budd-Chiari syndrome: Management and long-term results of 60 patients. World J Clin Cases 2020; 8(14): 2930-2941
|
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i14/2930.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i14.2930 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
